By Emily Moulton, National Clinical Program Manager, Urology and Critical Care at BD, and Hannah Hinsley, Clinical Connect Program Specialist, Urology and Critical Care at BD In our work ...

FRANKLIN LAKES, N.J., June 26, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced the commercial launch of a new single-cell ...

Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S.

Represents costs recorded to Other operating expense, net, incurred in connection with the separation of our former Biosciences and Diagnostic Solutions business and the combination of the business ...

Amount reflects the estimated impact to adjusted diluted earnings per share for fiscal year 2025 from the proposed disposition of the Bioscience and Diagnostics Solutions business that will be ...

Represents costs recorded to Other operating expense, net incurred in connection with the proposed combination of our Biosciences and Diagnostic Solutions business with Waters Corporation.

- Addition of Parata aligns with two key tenets of BD's innovation strategy: driving smart, connected care and enabling new care settings FRANKLIN LAKES, N.J., July 18, 2022 /PRNewswire/ -- BD (Becton ...

FRANKLIN LAKES, N.J. (Sept. 12, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today expanded their Class I voluntary recall to include 15 ...

FRANKLIN LAKES, N.J. (July 9, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been named among the top-performing U.S.-based companies by TIME.

I’m proud to share the early success of BD’s partnership with the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). What began as a new opportunity to support the ...

FRANKLIN LAKES, N.J., Jan. 9, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new survey, revealing ...